Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Xiang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0016-6233; OpenAlex author ID A5100331028. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Systemic Treatment Followed by Radical Resection Combined With Intestinal Autotransplantation for Locally Advanced Pancreatic Cancer: A Retrospectively Observa… Co-author DOI 10.1097/sla.0000000000006600↗
  2. Construction of feature selection and efficacy prediction model for transformation therapy of locally advanced pancreatic cancer based on CT, 18F-FDG PET/CT, D… First author DOI 10.1186/s12935-025-03639-8↗
  3. 18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.2967/jnumed.123.266283↗
  4. Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological c… Last author DOI 10.1007/s00259-022-06100-4↗
  5. Comparing the clinical value of baseline [68 Ga]Ga-FAPI-04 PET/CT and [18F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the… Co-author DOI 10.1007/s00259-023-06297-y↗
  6. Carbon Dioxide-Derived Biodegradable and Cationic Polycarbonates as a New siRNA Carrier for Gene Therapy in Pancreatic Cancer. Co-author DOI 10.3390/nano11092312↗
  7. Intrafraction tumor motion during deep inspiration breath hold pancreatic cancer treatment. Co-author DOI 10.1002/acm2.12577↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingbo Liang · 2 shared papers, 2024–2026 · strength 0.46
  2. Xueli Bai · 2 shared papers, 2024–2026 · strength 0.46
  3. Xinhui Su · 2 shared papers, 2024–2026 · strength 0.46
  4. Zhixin Hao · 2 shared papers, 2023 · strength 0.33
  5. Qiaofei Liu · 2 shared papers, 2023 · strength 0.33
  6. Jie Ding · 2 shared papers, 2023 · strength 0.33
  7. Hua Huang · 2 shared papers, 2023 · strength 0.33
  8. Li Huo · 2 shared papers, 2023 · strength 0.33
  9. Jiangdong Qiu · 2 shared papers, 2023 · strength 0.33
  10. Taiping Zhang · 2 shared papers, 2023 · strength 0.33
  11. Liang Qi · 1 shared paper, 2025 · strength 0.27
  12. Juan Du · 1 shared paper, 2025 · strength 0.27
  13. Baorui Liu · 1 shared paper, 2025 · strength 0.27
  14. Guoliang Qiao · 1 shared paper, 2026 · strength 0.26
  15. Tao Ma · 1 shared paper, 2026 · strength 0.26
  16. Qi Zhang · 1 shared paper, 2026 · strength 0.26
  17. Tianan Jiang · 1 shared paper, 2026 · strength 0.26
  18. Lili Lin · 1 shared paper, 2024 · strength 0.20
  19. Wenming Wu · 1 shared paper, 2023 · strength 0.17
  20. Wenming Wu · 1 shared paper, 2023 · strength 0.17
  21. Xinmeng Zhang · 1 shared paper, 2021 · strength 0.11
  22. Ken‐Tye Yong · 1 shared paper, 2021 · strength 0.11
  23. Chengbin Yang · 1 shared paper, 2021 · strength 0.11
  24. Tianfang Li · 1 shared paper, 2019 · strength 0.10
  25. Chuan Zeng · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.